Breaking News Instant updates and real-time market news.

PFPT

Proofpoint

$125.79

0.19 (0.15%)

, CRM

Salesforce

$154.80

4.85 (3.23%)

08:29
09/12/19
09/12
08:29
09/12/19
08:29

Proofpoint appoints Peter Leav, Leyla Seka to board of directors

Proofpoint (PFPT) announced its board of directors has appointed Peter Leav and Leyla Seka as new independent directors, effective July 24, 2019. Leav was most recently the president, chief executive officer, and director of BMC Software. Leyla Seka spent 11 years at Salesforce (CRM) where she most recently served as the executive vice president of the Salesforce Mobile platform experience.

PFPT

Proofpoint

$125.79

0.19 (0.15%)

CRM

Salesforce

$154.80

4.85 (3.23%)

  • 10

    Oct

  • 15

    Oct

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

PFPT Proofpoint
$125.79

0.19 (0.15%)

07/26/19
NEED
07/26/19
NO CHANGE
Target $150
NEED
Buy
Proofpoint price target raised to $150 from $135 at Needham
Needham analyst Alex Henderson raised his price target on Proofpoint to $150 and kept his Buy rating after its beat-and-raise Q2 results, with "strong" operating leverage and "excellent" free cash flows driving the company's longer-term targets ahead of schedule. The analyst adds that Proofpoint's international opportunity is a "key part" of his investment thesis, with revenues growing 33% in the most recent quarter but still accounting for just 19% of the total.
07/29/19
JMPS
07/29/19
NO CHANGE
Target $140
JMPS
Outperform
Proofpoint price target raised to $140 from $130 at JMP Securities
JMP Securities analyst Erik Suppiger raised his price target on Proofpoint shares to $140 from $130 after the company reported better than expected Q2 results and guided billings, revenue and EPS above consensus for the next quarter. The analyst, who previously projected a decline in gross margins, noted that their advance exceeded his expectations, said that Proofpoint's emerging products continue to perform well, and that the company's Wombat phishing training product is gaining "significant momentum." Suppiger keeps an Outperform rating on Proofpoint shares.
08/13/19
BOFA
08/13/19
NO CHANGE
Target $103
BOFA
Buy
Crowdstrike price target raised to $103 from $89 at BofA/Merrill
BofA Merrill Lynch analyst Tal Liani noted that he had expected and incorporated some share gains for Crowdstrike (CRWD) from Symantec (SYMC) in his model, but following the recent announcement that Broadcom (AVGO) intends to buy Symantec's enterprise business he sees the potential for those share gains to accelerate. Liani, who raised his price target on Crowdstrike shares to $103 from $89, reiterated a Buy rating on the stock. Aside from the potential for Crowdstrike in antivirus, Liani sees other areas of cyber security where Symantec leads and he could see shares losses should Broadcom's deal create any uncertainty around Symantec's roadmap or commitment to R&D in the space. In email security the beneficiaries would be Proofpoint (PFPT) and Mimecast (MIME) and in secure web gateways the beneficiary could be Zscaler (ZS), Liani noted.
09/04/19
DBAB
09/04/19
UPGRADE
DBAB
Buy
Proofpoint upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Karl Keirstead upgraded Proofpoint to Buy from Hold.
CRM Salesforce
$154.80

4.85 (3.23%)

08/23/19
RBCM
08/23/19
NO CHANGE
Target $200
RBCM
Outperform
Salesforce price target raised to $200 from $181 at RBC Capital
RBC Capital analyst Alex Zukin assumed the coverage and raised his price target on Salesforce to $200 while keeping an Outperform rating after the company's Q2 earnings beat and raised FY20 guidance. The analyst cites "little meaningful competition" and no evidence of pricing pressure or market saturation at Salesforce, saying its current valuation of 5.5-times enterprise value to expected 2021 revenue represents a "buying opportunity". Zukin is also positive on the company's "uniquely strong" CEO steering Salesforce to become a "System of Customer Intelligence".
08/23/19
BARD
08/23/19
NO CHANGE
Target $175
BARD
Outperform
Salesforce remains best way to play Digital Transformation, says Baird
Baird analyst Rob Oliver said the Salesforce Q2 results will likely be a relief to investors who worried about the broader macro environment, recent pace of acquisitions, competition, and foreign exchange headwinds. The analyst said Digital Transformation remains a massive driver for Salesforce and it remains the best way to play that theme. Olive reiterated his Outperform rating and $175 price target on Salesforce shares.
08/23/19
RHCO
08/23/19
NO CHANGE
Target $195
RHCO
Buy
Salesforce price target raised to $195 from $189 at SunTrust
SunTrust analyst Terry Tillman raised his price target on Salesforce to $195 and kept his Buy rating after its "solid" Q2 results with upside in a "number of key metrics". The analyst notes the raised guidance was also supported by the timing of recent acquisitions, and he boosts his FY20 and FY21 earnings estimates by 13c and 4c to $2.83 and $3.03 respectively. Tillman adds that the valuation on Salesforce at 8-times his expected 2020 revenue estimate is in line with the 20%-30% growth peer group.
09/04/19
RBCM
09/04/19
NO CHANGE
Target $165
RBCM
Outperform
Coupa Software price target raised to $165 from $135 at RBC Capital
RBC Capital analyst Alex Zukin assumed coverage of Coupa Software (COUP) with an unchanged Outperform rating and a raised price target of $165, up from $135 prior. The analyst says the company's best-in-class position in application platform, along with a large networked user/supplier community make it a legitimate market standard comparable to Salesforce (CRM) in CRM, Workday (WDAY) in HCM, or ServiceNow (NOW) in IT. Zukin believes that Coupa Software has a long runway toward sustaining growth rate of over 30% and "meaningful" near-term upside potential.

TODAY'S FREE FLY STORIES

11:06
10/15/19
10/15
11:06
10/15/19
11:06
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

11:06
10/15/19
10/15
11:06
10/15/19
11:06
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

BBBY

Bed Bath & Beyond

$12.35

0.06 (0.49%)

, LOW

Lowe's

$112.40

1.735 (1.57%)

11:05
10/15/19
10/15
11:05
10/15/19
11:05
On The Fly
Bed Bath & Beyond, Lowe's upgrades among today's top analyst calls »

Check out today's top…

BBBY

Bed Bath & Beyond

$12.35

0.06 (0.49%)

LOW

Lowe's

$112.40

1.735 (1.57%)

BLMN

Bloomin' Brands

$17.61

-0.54 (-2.98%)

SFIX

Stitch Fix

$21.07

-0.14 (-0.66%)

NVDA

Nvidia

$194.87

8.36 (4.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 20

    Nov

  • 20

    Nov

GS

Goldman Sachs

$201.90

-3.91 (-1.90%)

11:05
10/15/19
10/15
11:05
10/15/19
11:05
Hot Stocks
Goldman Sachs sees global GDP growth in excess of 3% for this year and next »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

BHC

Bausch Health

$21.10

0.19 (0.91%)

11:04
10/15/19
10/15
11:04
10/15/19
11:04
Periodicals
Breaking Periodicals news story on Bausch Health »

Citron Research says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

ON

ON Semiconductor

$19.52

0.65 (3.44%)

11:03
10/15/19
10/15
11:03
10/15/19
11:03
Hot Stocks
ON Semiconductor, Almotive collaborate on prototype sensor fusion platforms »

ON Semiconductor and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

MDP

Meredith

$35.26

0.56 (1.61%)

11:02
10/15/19
10/15
11:02
10/15/19
11:02
Hot Stocks
Meredith appoints Daphne Kwon Chief Strategy Officer »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

NURO

NeuroMetrix

$0.32

-0.0096 (-2.91%)

11:02
10/15/19
10/15
11:02
10/15/19
11:02
Hot Stocks
NeuroMetrix shifting to exclusively direct-to-consumer model for Quell 2.0 »

NeuroMetrix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

WSLFF

Westleaf

$0.00

(0.00%)

11:01
10/15/19
10/15
11:01
10/15/19
11:01
Hot Stocks
Westleaf announces receipt of Health Canada standarad processing license »

Westleaf announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZM

Zoom Video

$69.25

-1.58 (-2.23%)

10:55
10/15/19
10/15
10:55
10/15/19
10:55
Options
Zoom Video Communications put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Dec

BHKLY

BOC Hong Kong

$0.00

(0.00%)

10:53
10/15/19
10/15
10:53
10/15/19
10:53
Upgrade
BOC Hong Kong rating change  »

BOC Hong Kong upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGLD

Royal Gold

$118.16

-6.81 (-5.45%)

10:48
10/15/19
10/15
10:48
10/15/19
10:48
Hot Stocks
Royal Gold appoints Mark Isto as COO, Paul Libner as CFO »

Royal Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

10:45
10/15/19
10/15
10:45
10/15/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
10/15/19
10/15
10:45
10/15/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

TNDM

TNDM

, ABT

Abbott

$81.40

1.59 (1.99%)

10:44
10/15/19
10/15
10:44
10/15/19
10:44
On The Fly
Tandem Diabetes jumps after announcing partnership with Abbott »

Shares of Tandem Diabetes…

TNDM

TNDM

ABT

Abbott

$81.40

1.59 (1.99%)

DXCM

DexCom

$149.39

-10.81 (-6.75%)

PODD

Insulet

$154.18

1.88 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 13

    Nov

  • 14

    Nov

RETA

Reata Pharmaceuticals

$155.99

55.62 (55.42%)

10:43
10/15/19
10/15
10:43
10/15/19
10:43
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMR

Emerson

$67.29

0.08 (0.12%)

10:42
10/15/19
10/15
10:42
10/15/19
10:42
Hot Stocks
Emerson says will 'carefully evaluate' D.E. Shaw's proposals »

Emerson confirmed receipt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BAC

Bank of America

$29.43

0.28 (0.96%)

10:38
10/15/19
10/15
10:38
10/15/19
10:38
Hot Stocks
Bank of America reports September charge-off rate 2.62% vs. 2.67% last month »

Reports September 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

GM

General Motors

$35.89

0.38 (1.07%)

10:36
10/15/19
10/15
10:36
10/15/19
10:36
Periodicals
General Motors, UAW closer to reaching agreement, says Phil LeBeau »

CNBC contributor Phil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SPY

SPDR S&P 500 ETF Trust

$298.16

2.15 (0.73%)

, SPX

S&P 500

$0.00

(0.00%)

10:35
10/15/19
10/15
10:35
10/15/19
10:35
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

EU negotiators closing in…

SPY

SPDR S&P 500 ETF Trust

$298.16

2.15 (0.73%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRAY

ViewRay

$2.69

0.115 (4.47%)

10:35
10/15/19
10/15
10:35
10/15/19
10:35
Recommendations
ViewRay analyst commentary  »

ViewRay preannounced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

INSW

International Seaways

$25.60

-0.28 (-1.08%)

10:29
10/15/19
10/15
10:29
10/15/19
10:29
Conference/Events
International Seaways management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

AXL

American Axle

$8.03

0.165 (2.10%)

10:25
10/15/19
10/15
10:25
10/15/19
10:25
Options
American Axle call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNS

WNS Holdings

$59.25

-0.77 (-1.28%)

10:25
10/15/19
10/15
10:25
10/15/19
10:25
Conference/Events
WNS Holdings management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 11

    Nov

C

Citi

$70.26

-0.02 (-0.03%)

10:23
10/15/19
10/15
10:23
10/15/19
10:23
Hot Stocks
Breaking Hot Stocks news story on Citi »

Citi says accrual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.